Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportPrograms, Funding & Financing Search Results « » The Henry J. Kaiser Family Foundation

Programs, Funding & Financing

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Independent Panel Calls For Stronger Financial Safeguards For Global Fund

After a six-month review of the financial systems at the Global Fund to Fight AIDS, Tuberculosis and Malaria, a seven-member independent panel “recommended a substantial overhaul Monday in the grant organization’s practices,” the Wall Street Journal reports. The panel, led by former U.S. Secretary of Health and Human Services Michael Leavitt and former Botswana President Festus Mogae, “said in a report the fund must improve risk management, simplify grant application processes, and place greater emphasis on results,” according to the newspaper.

NCD Draft Declaration Lacks Specific Targets, Calls For Nations To Adopt Recommendations For Reducing Chronic Disease Deaths

“World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable ‘lifestyle’ diseases,” including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), “amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries,” the Guardian reports. “The scale and disastrous potential of these diseases has led the U.N. to call only its second high-level summit on a health issue on Monday — the first was over AIDS in 2001. Months of negotiation have led to a draft declaration [.pdf] that will be signed at the summit,” the newspaper writes (Boseley, 9/16).

Major Donors Should Consider Funding For Potential Malaria Vaccine

When the results of a large clinical trial testing the effectiveness of the RTS,S malaria vaccine among children in Africa are made available later this year, “it will be time to start discussing what to do with the vaccine,” Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, writes in a Huffington Post opinion piece. “If the vaccine is safe and effective, one of the most important questions will be how to pay for it … and even though Andrew Witty, the CEO of the vaccine’s manufacturer, GSK, has promised to price the vaccine at a point just above its production cost, this price may still end up being too high for many malaria-affected countries to pay for it,” he writes.

WHO, WEF Reports Examine Cost Of Treating And Preventing, Economic Burden Of NCDs

Low-income countries “could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday” in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports (Kelland, 9/19).

'ScienceSpeaks' Interviews Director Of Technical Leadership At OGAC

The Center for Global Health Policy’s “ScienceSpeaks” blog features an interview with Caroline Ryan, director of technical leadership at the Office of U.S. Global AIDS Coordinator (OGAC), where she has worked for seven years. Ryan discusses PEPFAR program implementation, circumcision as an HIV prevention tool and balancing efficiency with the…

GlobalPost Examines GHI In Kenya

As part of its special report “Healing the World,” GlobalPost examines how the Obama administration’s Global Health Initiative (GHI) is affecting U.S. health-related work in Kenya.

Global Trade Negotiations Must Consider Inequalities In Access To Medicines

Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York “are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices,” James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece. “By continuing to assert that the Doha Declaration is in fact limited in various ways, U.S. and European trade negotiators have tried to discourage the granting of compulsory licenses on patents for high-priced drugs for cancer and other non-communicable diseases,” he continues, before outlining a proposal called the “cancer prize approach” that would de-link drug prices from research and development incentives.

WHO Mandated To Lead Global Response Against NCDs But Funding Lacking

In this post in the Center for Global Development’s “Global Health Policy” blog, Amanda Glassman, director of global health policy and a research fellow at the center, writes that the “main outcome” of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) is an assignment for the WHO “to lead the…

U.N. Calls For Advancement On Goal To Save Women And Children; Poorest Countries, Drug Company Contribute To Fight

Speaking at a high-level meeting at U.N. headquarters on Tuesday, U.N. Secretary-General Ban Ki-moon, while lauding the progress made under the Every Woman Every Child initiative since its launch one year ago, noted that millions of women and children “are still dying needless deaths and called for advancing the goal of saving 16 million lives by 2015,” the U.N. News Centre reports. A one-year progress update launched at the meeting, Saving the Lives of 16 Million, “shows that in the first year of the effort, commitments have been implemented and enhanced, new partners have come on board, funding has been increased, policies improved and services strengthened on the ground,” according to the news service (9/20).